<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Bras Pneumol</journal-id>
      <journal-id journal-id-type="iso-abbrev">J Bras Pneumol</journal-id>
      <journal-title-group>
        <journal-title>Jornal Brasileiro de Pneumologia : Publica&#xE7;a&#x30B;o Oficial da Sociedade Brasileira de Pneumologia e Tisilogia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1806-3713</issn>
      <issn pub-type="epub">1806-3756</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Pneumologia e Tisiologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24831404</article-id>
      <article-id pub-id-type="pmc">4083639</article-id>
      <article-id pub-id-type="publisher-id">S1806-37132014000200183</article-id>
      <article-id pub-id-type="doi">10.1590/S1806-37132014000200013</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>The value of family history in the diagnosis of hypersensitivity
pneumonitis in children<xref ref-type="fn" rid="fn01">*</xref>
</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Cardoso</surname>
            <given-names>Joana</given-names>
          </name>
          <role>Intern in the Department of Pediatrics</role>
          <aff>Vila Nova de Gaia/Espinho Hospital Center, Porto,
<country>Portugal</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Carvalho</surname>
            <given-names>Isabel</given-names>
          </name>
          <role>Attending Physician</role>
          <aff>Vila Nova de Gaia/Espinho Hospital Center, Porto,
<country>Portugal</country></aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <corresp id="c01"><bold>Correspondence to: </bold>Joana Filipa Almeida Cardoso Rua Costa Fontes, 118,
4460-289, Matosinhos, Portugal Tel. 351 96 617-6396 E-mail:
<email>jfcardoso@yahoo.com</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Mar-Apr</season>
        <year>2014</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Mar-Apr</season>
        <year>2014</year>
      </pub-date>
      <volume>40</volume>
      <issue>2</issue>
      <fpage>183</fpage>
      <lpage>187</lpage>
      <history>
        <date date-type="received">
          <day>05</day>
          <month>12</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>16</day>
          <month>5</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Hypersensitivity pneumonitis (HP), or extrinsic allergic alveolitis, is an
immunologically mediated disease resulting from the inhalation of organic substances
that trigger an inflammatory response in the alveolar wall, bronchioles, and
interstitium in susceptible individuals. Although HP is predominantly an occupational
disease, seen in adulthood, cases in children have been described. The diagnosis of
HP requires a high degree of suspicion. The treatment consists in avoiding contact
with the antigen, and, in some cases, systemic corticosteroids might be necessary in
order to prevent its progression to pulmonary fibrosis. We report the clinical cases
of three children with a history of contact with birds and a family history of HP.
All three patients presented with cough and dyspnea on exertion. The disease was
diagnosed on the basis of the clinical history and ancillary diagnostic test results
consistent with the diagnosis, including a predominance of lymphocytes (&gt; 60%,
CD8+ T lymphocytes in particular) in bronchoalveolar lavage fluid and a ground-glass
pattern seen on HRCT of the chest. Early diagnosis is crucial in order to prevent HP
from progressing to pulmonary fibrosis. Hereditary factors seem to influence the
onset of the disease.</p>
      </abstract>
      <kwd-group>
        <kwd>Alveolitis, extrinsic allergic</kwd>
        <kwd>Bronchoalveolar lavage</kwd>
        <kwd>Glucocorticoids</kwd>
      </kwd-group>
      <counts>
        <fig-count count="3"/>
        <ref-count count="8"/>
        <page-count count="5"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>Hypersensitivity pneumonitis (HP), or extrinsic allergic alveolitis, is an
immunologically mediated disease caused by the inhalation of organic substances that, in
susceptible individuals, trigger an inflammatory response in the alveolar wall,
bronchioles, and interstitium.<sup>(</sup>
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>-</sup>
<xref rid="B08" ref-type="bibr">
<sup>8</sup>
</xref>
<sup>)</sup> Although HP is predominantly an occupational disease, seen in adulthood,
cases in children have been described, most of which occurred after exposure to avian
proteins.<sup>(</sup>
<xref rid="B04" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>,</sup>
<xref rid="B06" ref-type="bibr">
<sup>6</sup>
</xref>
<sup>)</sup>
</p>
      <p>The prevalence of HP ranges from 5-15% in individuals exposed to one
allergen,<sup>(</sup>
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>-</sup>
<xref rid="B03" ref-type="bibr">
<sup>3</sup>
</xref>
<sup>)</sup> and the frequency of the disease is related to several factors (the amount
of allergen inhaled, the duration of exposure, the nature of the antigen, and the host
immune response).<sup>(</sup>
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>,</sup>
<xref rid="B02" ref-type="bibr">
<sup>2</sup>
</xref>
<sup>)</sup> Heredity may play an important role, with families positive for HLA-DR7,
HLA-B8, and HLA-DQw3 showing a stronger predisposition.<sup>(</sup>
<xref rid="B02" ref-type="bibr">
<sup>2</sup>
</xref>
<sup>,</sup>
<xref rid="B06" ref-type="bibr">
<sup>6</sup>
</xref>
<sup>)</sup>
</p>
      <p>HP can be classified on the basis of symptoms (as acute, subacute, or chronic) or on the
basis of the dynamic nature of the disease (as acute progressive, acute intermittent
non-progressive, or recurrent non-acute disease).<sup>(</sup>
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>-</sup>
<xref rid="B03" ref-type="bibr">
<sup>3</sup>
</xref>
<sup>,</sup>
<xref rid="B05" ref-type="bibr">
<sup>5</sup>
</xref>
<sup>-</sup>
<xref rid="B06" ref-type="bibr">
<sup>6</sup>
</xref>
<sup>,</sup>
<xref rid="B08" ref-type="bibr">
<sup>8</sup>
</xref>
<sup>)</sup> The acute form corresponds to intermittent, intense allergen exposure, and
it is similar to a respiratory infection of viral etiology that resolves within 24-48
h.<sup>(</sup>
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>-</sup>
<xref rid="B03" ref-type="bibr">
<sup>3</sup>
</xref>
<sup>,</sup>
<xref rid="B05" ref-type="bibr">
<sup>5</sup>
</xref>
<sup>-</sup>
<xref rid="B07" ref-type="bibr">
<sup>7</sup>
</xref>
<sup>)</sup> The subacute form is characterized by dyspnea on exertion, asthenia, and
weight loss, and it corresponds to continued but less intense allergen
exposure.<sup>(</sup>
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>-</sup>
<xref rid="B03" ref-type="bibr">
<sup>3</sup>
</xref>
<sup>,</sup>
<xref rid="B05" ref-type="bibr">
<sup>5</sup>
</xref>
<sup>-</sup>
<xref rid="B06" ref-type="bibr">
<sup>6</sup>
</xref>
<sup>)</sup> The chronic form is characterized by progression to irreversible lung
injury, with pulmonary fibrosis,<sup>(</sup>
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>,</sup>
<xref rid="B03" ref-type="bibr">
<sup>3</sup>
</xref>
<sup>)</sup> and it corresponds to prolonged insidious inhalation of low concentrations
of antigen, with no history of acute disease.<sup>(</sup>
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>-</sup>
<xref rid="B03" ref-type="bibr">
<sup>3</sup>
</xref>
<sup>,</sup>
<xref rid="B05" ref-type="bibr">
<sup>5</sup>
</xref>
<sup>-</sup>
<xref rid="B07" ref-type="bibr">
<sup>7</sup>
</xref>
<sup>)</sup>
</p>
      <p>There is no pathognomonic diagnostic test, and a presumptive diagnosis is made on the
basis of a high index of suspicion, clinical history, physical examination, laboratory
test results, pulmonary function testing (PFT), and imaging study results.<sup>(</sup>
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>-</sup>
<xref rid="B04" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>,</sup>
<xref rid="B06" ref-type="bibr">
<sup>6</sup>
</xref>
<sup>)</sup>
</p>
      <p>Laboratory data are nonspecific-leukocytosis, increased ESR, and increased levels of
C-reactive protein (CRP) and immunoglobulin.<sup>(</sup>
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>,</sup>
<xref rid="B02" ref-type="bibr">
<sup>2</sup>
</xref>
<sup>,</sup>
<xref rid="B04" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>)</sup> Skin tests and the presence of precipitating antibodies to the antigen are
markers of exposure, but negative results do not exclude the diagnosis.<sup>(</sup>
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>-</sup>
<xref rid="B04" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>,</sup>
<xref rid="B06" ref-type="bibr">
<sup>6</sup>
</xref>
<sup>)</sup> Inhalation challenge testing with the predisposing antigen is the best
diagnostic method when diagnostic questions persist, but it must be performed in a
hospital setting.<sup>(</sup>
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>-</sup>
<xref rid="B04" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>,</sup>
<xref rid="B06" ref-type="bibr">
<sup>6</sup>
</xref>
<sup>)</sup>
</p>
      <p>Usually, PFT shows a restrictive pattern, characterized by a decrease in FVC and TLC. In
the chronic phase, it is possible to find an obstructive pattern, and DLCO is usually
decreased.<sup>(</sup>
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>-</sup>
<xref rid="B04" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>,</sup>
<xref rid="B06" ref-type="bibr">
<sup>6</sup>
</xref>
<sup>)</sup>
</p>
      <p>Bronchoalveolar lavage (BAL) fluid shows a predominance of lymphocytes (&gt; 60%),
namely suppressor T lymphocytes (CD8+), with a decrease in the CD4/CD8 index &lt; 1%
(rarely found in children).<sup>(</sup>
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>-</sup>
<xref rid="B04" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>,</sup>
<xref rid="B06" ref-type="bibr">
<sup>6</sup>
</xref>
<sup>)</sup>
</p>
      <p>Chest X-ray changes appear as a function of the degree of disease and are little related
to symptom severity, ranging from normal to a nodular/reticulonodular pattern (in acute
and subacute forms).<sup>(</sup>
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>-</sup>
<xref rid="B06" ref-type="bibr">
<sup>6</sup>
</xref>
<sup>)</sup> Chest HRCT can show a diffuse micronodular pattern (acute phase) or
obstructive emphysema, interstitial fibrotic lesions, and ground-glass areas (chronic
phase),<sup>(</sup>
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>-</sup>
<xref rid="B07" ref-type="bibr">
<sup>7</sup>
</xref>
<sup>)</sup> being the most useful test for diagnosis.</p>
      <p>The treatment consists in avoiding contact with the antigen, which can be the sole
treatment in acute forms. Systemic corticosteroids are the treatment of choice in
subacute and chronic forms.<sup>(</sup>
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>-</sup>
<xref rid="B04" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>,</sup>
<xref rid="B06" ref-type="bibr">
<sup>6</sup>
</xref>
<sup>)</sup> The prognosis varies from full recovery in acute and non-progressive forms
to pulmonary fibrosis in chronic forms. The degree of pulmonary fibrosis at diagnosis is
the major prognostic factor.<sup>(</sup>
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>,</sup>
<xref rid="B02" ref-type="bibr">
<sup>2</sup>
</xref>
<sup>)</sup>
</p>
    </sec>
    <sec>
      <title>Case reports</title>
      <p>Case 1</p>
      <p>We report the case of a 12-year-old boy with a history of asthma and a family history of
HP. Living in a rural area, the boy had contact with pigeons and canaries, which
aggravated the symptoms. He presented to the emergency room with a 2-day history of
productive cough and fever, accompanied by anorexia and weight loss. A chest X-ray
showed a bilateral perihilar infiltrate, and the patient was discharged after being
treated with clarithromycin, which was replaced by a combination of amoxicillin and
clavulanic acid 5 days later because of persistence of symptoms. One month later,
because the patient continued to have an intermittent cough with periods of worsening
and dyspnea on minimal exertion, he again sought medical attention, presenting with
perioral cyanosis, pallor, hypoxemia (SpO<sub>2</sub> = 85% on room air), overall
retraction, and an overall decrease in breath sounds, with crackles at the lung bases.
Ancillary test results were as follows: ESR, 36 mm/h; PCR, 22.8 mg/L; IgA and IgG
levels, increased; Phadiatop<sup>(r)</sup> test (Phadia, Uppsala, Sweden) for inhalation
and food allergy, negative; PPD, 0 mm induration; sweat test, 34 mEq/L; chest X-ray
findings, bilateral perihilar and basilar reticulonodular infiltrate (<xref ref-type="fig" rid="f01">Figure 1</xref>); echocardiogram, unremarkable; chest HRCT
findings, air-space consolidation and air bronchogram in both lower lobes, accompanied
by a diffusely distributed bilateral interstitial pattern, a centrilobular pattern with
some micronodules, and ground-glass areas; serology for <italic>Chlamydophila
psittaci</italic>, negative; PFT, indicative of mild obstructive lung disease; DLCO,
moderate defect; BAL fluid findings, an intense lymphocytic alveolitis, with a marked
predominance of CD8+ (CD4/CD8 ratio &lt; 0.3%). The patient received oral
corticosteroids for a year, which resulted in complete resolution of the symptoms and
complete resolution of the lesions seen on HRCT of the chest, as well as in improvement
in PFT results by the end of a three-year follow-up period.</p>
      <p>
<fig id="f01" orientation="portrait" position="float"><label>Figure 1</label><caption><title>Chest X-ray showing bilateral perihilar and basilar reticulonodular
infiltrate.</title></caption><graphic xlink:href="1806-3713-jbpneu-40-02-00183-gf01"/></fig>
</p>
    </sec>
    <sec>
      <title>Case 2</title>
      <p>A 14-year-old girl who lived in a rural area and had birds at home presented with a
family history of HP. The patient had been healthy until November of 2002, when she
sought emergency room treatment due to fever and cough. Physical examination revealed
crackles and respiratory distress. A chest X-ray showed an interstitial infiltrate. The
patient was discharged on clarithromycin and prednisolone. She returned to the
outpatient clinic one week later, reporting dyspnea on minimal exertion. Ancillary test
results were as follows: ESR, 24 mm/h; IgG level, increased; levels of other
immunoglobulins, no abnormalities; serologies for <italic>Mycoplasma pneumoniae</italic>
and <italic>Chlamydia pneumoniae</italic>, negative; IgG and IgM, negative; chest X-ray
findings, increased bronchovascular markings bilaterally and bilateral, perihilar
predominant diffuse interstitial infiltrate; chest HRCT findings, mild, slightly
heterogeneously distributed parenchymal thickening in both lungs, small nodules with
ill-defined borders, and ground-glass changes (<xref ref-type="fig" rid="f02">Figure
2</xref>); echocardiogram and electrocardiogram, unremarkable; BAL fluid findings, an
intense lymphocytic alveolitis and a mild neutrophilic alveolitis, with a marked
predominance of CD8+ (CD4/CD8 ratio &lt; 0.1%). The patient was maintained on inhaled
corticosteroids for 2 years, which resulted in progressive clinical improvement.</p>
      <p>
<fig id="f02" orientation="portrait" position="float"><label>Figure 2</label><caption><title>HRCT scan of the chest showing mild, slightly heterogeneously distributed
parenchymal thickening in both lungs; small nodules with ill-defined borders;
and ground-glass changes.</title></caption><graphic xlink:href="1806-3713-jbpneu-40-02-00183-gf02"/></fig>
</p>
    </sec>
    <sec>
      <title>Case 3</title>
      <p>A 7-year-old boy, whose father and paternal grandmother were under investigation for
suspected HP, presented with a personal history of <italic>situs inversus
totalis</italic> and recurrent respiratory infection. The boy was admitted to the
emergency room with a 5-month history of productive cough, accompanied by progressively
worsening dyspnea on exertion, with no improvement with bronchodilators and inhaled
corticosteroids. It was reported that there had been a parakeet at home since the onset
of the symptoms, and that the home also had a henhouse and a cooperage. The initial
examination revealed an SpO<sub>2</sub> of 84% on room air, subcostal retraction, and
bilateral crackles. Ancillary test results were as follows: ESR, 30 mm/h; PCR, 1.41
mg/dL; IgG, IgA, and IgM levels, increased; serologies for <italic>Mycoplasma
pneumoniae, Legionella pneumophila</italic>, and<italic> Chlamydia
pneumoniae</italic> (IgG and IgM), negative; chest X-ray findings, bilateral diffuse
perihilar interstitial infiltrate; sweat test, 32 mEq/L; PPD, 0 mm induration; serum
precipitins to birds droppings and feathers, negative; echocardiogram, <italic>situs
inversus totalis</italic>; chest HRCT findings, pronounced ground-glass changes in
both lung fields, consistent with extrinsic allergic alveolitis (<xref ref-type="fig" rid="f03">Figure 3</xref>); PFT, indicative of severe obstructive lung disease that
was unresponsive to bronchodilators; BAL fluid findings, an intense lymphocytic
alveolitis and neutrophilia, with a marked predominance of CD8+ (CD4/CD8 ratio &lt;
0.1%). The patient received inhaled corticosteroids for 2 years, which resulted in
progressive clinical and radiological improvement.</p>
      <p>
<fig id="f03" orientation="portrait" position="float"><label>Figure 3</label><caption><title>HRCT scan of the chest showing pronounced ground-glass changes in both lung
fields, consistent with extrinsic allergic alveolitis.</title></caption><graphic xlink:href="1806-3713-jbpneu-40-02-00183-gf03"/></fig>
</p>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>The patients described had a family history of HP accompanied by a clinical profile that
corresponded to the subacute form of HP, with an obstructive pattern and symptoms such
as cough, dyspnea on exertion, weight loss, and sometimes fever, the onset of which
occurred within weeks to months of exposure to an antigen.</p>
      <p>A high index of suspicion was essential for the diagnosis, as were analytical and
laboratory criteria. Among the major criteria, defined by Schuyler et al.,<sup>(</sup>
<xref rid="B07" ref-type="bibr">
<sup>7</sup>
</xref>
<sup>)</sup> are symptoms consistent with the disease, evidence of exposure to antigens
as per clinical history, X-ray and CT findings consistent with HP, and lymphocytosis in
BAL fluid. Chief among the minor criteria are crackles at the lung bases and arterial
hypoxemia. In only one of the patients was there a decrease in DLCO. In none of the
cases was it possible to detect precipitating antibodies to the antigen. Although they
are objective markers of exposure, negative results do not absolutely exclude the
diagnosis.<sup>(</sup>
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>-</sup>
<xref rid="B04" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>,</sup>
<xref rid="B06" ref-type="bibr">
<sup>6</sup>
</xref>
<sup>)</sup>
</p>
      <p>In these three cases, it was possible to detect a diffuse reticulonodular/interstitial
pattern on chest X-ray, as well as a ground-glass pattern, ground-glass areas, and
micronodules, characteristic of the subacute form.</p>
      <p>The detection of lymphocytosis in the BAL fluid from the patients, as well as the
finding of a CD4/CD8 ratio &lt; 0.1% in two of them, lent support to the diagnosis of
HP.</p>
      <p>Given that the disease was not severe in any of the cases, the treatment consisted in
avoiding contact with the allergen and using oral/inhaled corticosteroids, which
resulted in progressive clinical improvement, as well as in improvement in radiological
and ventilatory parameters.</p>
      <p>The need for lung biopsy should be weighed in terms of its cost-benefit ratio, and it
should be considered in rare cases in which there is diagnostic uncertainty or in which
the clinical course or treatment response is unclear.<sup>(</sup>
<xref rid="B03" ref-type="bibr">
<sup>3</sup>
</xref>
<sup>)</sup>
</p>
      <p>HP is an uncommon disease in children and has nonspecific symptoms. For the diagnosis of
HP, it is important that clinical evaluation be performed and allergen exposure be
investigated. In all three cases described above, the patients had a family history of
HP, although they were not screened for the presence of HLA. These facts lead us to
believe that, although allergens are the major triggering factor for this disease,
heredity is also an important cofactor. Early diagnosis of HP is crucial in order to
prevent severe and irreversible complications, such as pulmonary fibrosis.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn id="fn01" fn-type="other">
        <label>*</label>
        <p>Study carried out at the Vila Nova de Gaia/Espinho Hospital Center, Porto,
Portugal.</p>
      </fn>
      <fn fn-type="financial-disclosure">
        <p>Financial support: None</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="B01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cort&#xE9;s</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title xml:lang="pt">Neumonitis por hipersensibilidad: Alveolitis al&#xE9;rgica
extr&#xED;nseca</article-title>
          <source>An Esp Pediatr</source>
          <year>2002</year>
          <volume>56</volume>
          <issue>2</issue>
          <fpage>46</fpage>
          <lpage>53</lpage>
        </element-citation>
      </ref>
      <ref id="B02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hirschmann</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Pipavath</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Godwin</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Hypersensitivity pneumonitis: a historical, clinical,
and radiologic review</article-title>
          <source>Radiographics</source>
          <year>2009</year>
          <volume>29</volume>
          <issue>7</issue>
          <fpage>1921</fpage>
          <lpage>1938</lpage>
          <pub-id pub-id-type="doi">10.1148/rg.297095707</pub-id>
          <pub-id pub-id-type="pmid">19926754</pub-id>
        </element-citation>
      </ref>
      <ref id="B03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Girard</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lacasse</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Cormier</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Hypersensitivity pneumonitis</article-title>
          <source>Allergy</source>
          <year>2009</year>
          <volume>64</volume>
          <issue>3</issue>
          <fpage>322</fpage>
          <lpage>334</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1398-9995.2009.01949.x</pub-id>
          <pub-id pub-id-type="pmid">19210361</pub-id>
        </element-citation>
      </ref>
      <ref id="B04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vizmanos Lamotte</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Estrada Fern&#xE1;ndez</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Medina Rams</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mu-oz Gall</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>A&#xED;sa Pardo</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Monz&#xF3;n Gasp&#xE0;</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Pigeon breeder's lung [Article in
Spanish]</article-title>
          <source>An Pediatr (Barc)</source>
          <year>2009</year>
          <volume>70</volume>
          <issue>4</issue>
          <fpage>362</fpage>
          <lpage>365</lpage>
          <pub-id pub-id-type="doi">10.1016/j.anpedi.2008.10.008</pub-id>
          <pub-id pub-id-type="pmid">19349032</pub-id>
        </element-citation>
      </ref>
      <ref id="B05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Silva</surname>
              <given-names>CI</given-names>
            </name>
            <name>
              <surname>Churg</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>M&#xFC;ller</surname>
              <given-names>NL</given-names>
            </name>
          </person-group>
          <article-title>Hypersensitivity pneumonitis: spectrum of
high-resolution CT and pathologic findings</article-title>
          <source>AJR Am J Roentgenol</source>
          <year>2007</year>
          <volume>188</volume>
          <issue>2</issue>
          <fpage>334</fpage>
          <lpage>344</lpage>
          <pub-id pub-id-type="doi">10.2214/AJR.05.1826</pub-id>
          <pub-id pub-id-type="pmid">17242239</pub-id>
        </element-citation>
      </ref>
      <ref id="B06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bourke</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Dalphin</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Boyd</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>McSharry</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Baldwin</surname>
              <given-names>CI</given-names>
            </name>
            <name>
              <surname>Calvert</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
          <article-title>Hypersensitivity pneumonitis: current
concepts</article-title>
          <source>Eur Respir J Suppl</source>
          <year>2001</year>
          <volume>32</volume>
          <fpage>81s</fpage>
          <lpage>92s</lpage>
          <pub-id pub-id-type="pmid">11816827</pub-id>
        </element-citation>
      </ref>
      <ref id="B07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schuyler</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Cormier</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>The diagnosis of hypersensitivity
pneumonitis</article-title>
          <source>Chest</source>
          <year>1997</year>
          <volume>111</volume>
          <issue>3</issue>
          <fpage>534</fpage>
          <lpage>536</lpage>
          <pub-id pub-id-type="doi">10.1378/chest.111.3.534</pub-id>
          <pub-id pub-id-type="pmid">9118683</pub-id>
        </element-citation>
      </ref>
      <ref id="B08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leite</surname>
              <given-names>MMR</given-names>
            </name>
            <name>
              <surname>Valesan</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Gaiewski</surname>
              <given-names>CB</given-names>
            </name>
            <name>
              <surname>Falavigno</surname>
              <given-names>&#xCD;F</given-names>
            </name>
          </person-group>
          <article-title xml:lang="pt">Pneumonite de hipersensibilidade</article-title>
          <source>Rev AMRIGS</source>
          <year>2008</year>
          <volume>52</volume>
          <issue>4</issue>
          <fpage>321</fpage>
          <lpage>356</lpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article id="S01" article-type="translation" xml:lang="pt">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Relato De Caso</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>O valor da hist&#xF3;ria familiar no diagn&#xF3;stico de pneumonite de
hipersensibilidade em crian&#xE7;as<xref ref-type="fn" rid="fn02">*</xref>
</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Cardoso</surname>
            <given-names>Joana</given-names>
          </name>
          <role>M&#xE9;dica Interna de Pediatria</role>
          <aff>Centro Hospitalar de Vila Nova de Gaia/Espinho, Porto,
<country>Portugal</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Carvalho</surname>
            <given-names>Isabel</given-names>
          </name>
          <role>Assistente Hospitalar</role>
          <aff>Centro Hospitalar de Vila Nova de Gaia/Espinho, Porto,
<country>Portugal</country></aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <corresp id="c02"><bold>Endere&#xE7;o para correspond&#xEA;ncia:</bold> Joana Filipa Almeida Cardoso Rua Costa
Fontes, 118, 4460-289, Matosinhos, Portugal Tel. 351 96 617-6396 E-mail:
<email>jfcardoso@yahoo.com</email></corresp>
      </author-notes>
      <abstract>
        <p>A pneumonite de hipersensibilidade (PH), ou alveolite al&#xE9;rgica extr&#xED;nseca, &#xE9; uma
doen&#xE7;a imunologicamente mediada, resultante da inala&#xE7;&#xE3;o de subst&#xE2;ncias org&#xE2;nicas que
desencadeiam uma rea&#xE7;&#xE3;o inflamat&#xF3;ria na parede dos alv&#xE9;olos, bronqu&#xED;olos e
interst&#xED;cio em indiv&#xED;duos suscept&#xED;veis. Apesar de ser uma doen&#xE7;a ocupacional de
predom&#xED;nio na idade adulta, est&#xE3;o descritos casos em crian&#xE7;as. O diagn&#xF3;stico de PH
requer grande suspei&#xE7;&#xE3;o, e seu tratamento consiste na aus&#xEA;ncia de contato com o
ant&#xED;geno e, em alguns casos, pode ser necess&#xE1;ria corticoterapia sist&#xEA;mica,
evitando-se a progress&#xE3;o para fibrose pulmonar. Relatamos tr&#xEA;s casos cl&#xED;nicos de
crian&#xE7;as com hist&#xF3;ria de contato com aves e hist&#xF3;ria familiar de PH. Todos os casos
se apresentaram com tosse e dispneia aos esfor&#xE7;os. O diagn&#xF3;stico foi poss&#xED;vel por
hist&#xF3;ria cl&#xED;nica e exames auxiliares de diagn&#xF3;stico compat&#xED;veis, incluindo lavado
broncoalveolar com predom&#xED;nio de linf&#xF3;citos (&gt; 60%, especialmente linf&#xF3;citos T
CD8+) e TCAR de t&#xF3;rax com padr&#xE3;o em vidro fosco. O diagn&#xF3;stico precoce &#xE9; fundamental
na PH para se prevenir a evolu&#xE7;&#xE3;o para fibrose pulmonar. Fatores heredit&#xE1;rios parecem
influenciar seu aparecimento.</p>
      </abstract>
      <kwd-group>
        <kwd>Alveolite al&#xE9;rgica extr&#xED;nseca</kwd>
        <kwd>Lavagem broncoalveolar</kwd>
        <kwd>Glucocorticoides</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <sec>
        <title>Introdu&#xE7;&#xE3;o</title>
        <p>A pneumonite de hipersensibilidade (PH) ou alveolite al&#xE9;rgica extr&#xED;nseca &#xE9; uma doen&#xE7;a
mediada imunologicamente e causada pela inala&#xE7;&#xE3;o de subst&#xE2;ncias org&#xE2;nicas que, em
indiv&#xED;duos suscept&#xED;veis, desencadeia uma rea&#xE7;&#xE3;o inflamat&#xF3;ria na parede de alv&#xE9;olos,
bronqu&#xED;olos e interst&#xED;cio. <sup>(</sup>
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>-</sup>
<xref rid="B08" ref-type="bibr">
<sup>8</sup>
</xref>
<sup>)</sup> Apesar de ser uma doen&#xE7;a ocupacional de predom&#xED;nio na idade adulta,
est&#xE3;o descritos casos em crian&#xE7;as, na sua maioria ap&#xF3;s a exposi&#xE7;&#xE3;o a prote&#xED;nas
avi&#xE1;rias.<sup>(</sup>
<xref rid="B04" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>,</sup>
<xref rid="B06" ref-type="bibr">
<sup>6</sup>
</xref>
<sup>)</sup>
</p>
        <p>A preval&#xEA;ncia varia de 5-15% nos indiv&#xED;duos expostos a um al&#xE9;rgeno,<sup>(</sup>
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>-</sup>
<xref rid="B03" ref-type="bibr">
<sup>3</sup>
</xref>
<sup>)</sup> e a frequ&#xEA;ncia da doen&#xE7;a relaciona-se com v&#xE1;rios fatores (quantidade de
al&#xE9;rgeno inalado, dura&#xE7;&#xE3;o da exposi&#xE7;&#xE3;o, natureza do ant&#xED;geno e resposta imune do
hospedeiro).<sup>(</sup>
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>,</sup>
<xref rid="B02" ref-type="bibr">
<sup>2</sup>
</xref>
<sup>)</sup> A hereditariedade pode ser importante, se verificando maior
predisposi&#xE7;&#xE3;o em fam&#xED;lias com HLA-DR7, HLA-B8 e HLA-DQw3 positivos.<sup>(</sup>
<xref rid="B02" ref-type="bibr">
<sup>2</sup>
</xref>
<sup>,</sup>
<xref rid="B06" ref-type="bibr">
<sup>6</sup>
</xref>
<sup>)</sup>
</p>
        <p>A PH pode ser classificada segundo a sintomatologia (aguda, subaguda ou cr&#xF4;nica) ou
segundo a natureza din&#xE2;mica da doen&#xE7;a (aguda progressiva, aguda intermitente n&#xE3;o
progressiva ou doen&#xE7;a recorrente n&#xE3;o aguda).<sup>(</sup>
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>-</sup>
<xref rid="B03" ref-type="bibr">
<sup>3</sup>
</xref>
<sup>,</sup>
<xref rid="B05" ref-type="bibr">
<sup>5</sup>
</xref>
<sup>-</sup>
<xref rid="B06" ref-type="bibr">
<sup>6</sup>
</xref>
<sup>,</sup>
<xref rid="B08" ref-type="bibr">
<sup>8</sup>
</xref>
<sup>)</sup> A forma aguda corresponde a uma exposi&#xE7;&#xE3;o intermitente e intensa ao
al&#xE9;rgeno, que se assemelha a uma infec&#xE7;&#xE3;o respirat&#xF3;ria de etiologia viral que resolve
ao fim de 24-48 h.<sup>(</sup>
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>-</sup>
<xref rid="B03" ref-type="bibr">
<sup>3</sup>
</xref>
<sup>,</sup>
<xref rid="B05" ref-type="bibr">
<sup>5</sup>
</xref>
<sup>-</sup>
<xref rid="B07" ref-type="bibr">
<sup>7</sup>
</xref>
<sup>)</sup> A forma subaguda se caracteriza por dispneia aos esfor&#xE7;os, astenia e
perda ponderal, correspondendo a uma exposi&#xE7;&#xE3;o continuada mas menos intensa ao
al&#xE9;rgeno.<sup>(</sup>
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>-</sup>
<xref rid="B03" ref-type="bibr">
<sup>3</sup>
</xref>
<sup>,</sup>
<xref rid="B05" ref-type="bibr">
<sup>5</sup>
</xref>
<sup>-</sup>
<xref rid="B06" ref-type="bibr">
<sup>6</sup>
</xref>
<sup>)</sup> A forma cr&#xF4;nica se caracteriza pela progress&#xE3;o para les&#xE3;o pulmonar
irrevers&#xED;vel, com fibrose pulmonar,<sup>(</sup>
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>,</sup>
<xref rid="B03" ref-type="bibr">
<sup>3</sup>
</xref>
<sup>)</sup> correspondendo &#xE0; inala&#xE7;&#xE3;o insidiosa e prolongada de baixas concentra&#xE7;&#xF5;es
de ant&#xED;geno, sem quadro agudo pr&#xE9;vio.<sup>(</sup>
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>-</sup>
<xref rid="B03" ref-type="bibr">
<sup>3</sup>
</xref>
<sup>,</sup>
<xref rid="B05" ref-type="bibr">
<sup>5</sup>
</xref>
<sup>-</sup>
<xref rid="B07" ref-type="bibr">
<sup>7</sup>
</xref>
<sup>)</sup>
</p>
        <p>N&#xE3;o existe nenhum exame auxiliar de diagn&#xF3;stico patognom&#xF4;nico, sendo a hip&#xF3;tese
diagn&#xF3;stica colocada perante um elevado &#xED;ndice de suspei&#xE7;&#xE3;o, hist&#xF3;ria cl&#xED;nica, exame
objetivo, estudo laboratorial, provas de fun&#xE7;&#xE3;o respirat&#xF3;ria (PFR) e estudo de
imagem.<sup>(</sup>
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>-</sup>
<xref rid="B04" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>,</sup>
<xref rid="B06" ref-type="bibr">
<sup>6</sup>
</xref>
<sup>)</sup>
</p>
        <p>Os dados laboratoriais s&#xE3;o inespec&#xED;ficos - leucocitose, aumento da VHS e aumento dos
n&#xED;veis de prote&#xED;na C reativa (PCR) e de imunoglobulinas. <sup>(</sup>
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>,</sup>
<xref rid="B02" ref-type="bibr">
<sup>2</sup>
</xref>
<sup>,</sup>
<xref rid="B04" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>)</sup> Os testes cut&#xE2;neos e a presen&#xE7;a de anticorpos precipitantes para o
ant&#xED;geno s&#xE3;o marcadores de exposi&#xE7;&#xE3;o, mas a sua negatividade n&#xE3;o exclui o
diagn&#xF3;stico.<sup>(</sup>
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>-</sup>
<xref rid="B04" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>,</sup>
<xref rid="B06" ref-type="bibr">
<sup>6</sup>
</xref>
<sup>)</sup> As provas de provoca&#xE7;&#xE3;o mediante a inala&#xE7;&#xE3;o do ant&#xED;geno predisponente
s&#xE3;o o melhor m&#xE9;todo diagn&#xF3;stico na persist&#xEA;ncia de d&#xFA;vidas diagn&#xF3;sticas, mas essas
devem ser realizadas em meio hospitalar.<sup>(</sup>
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>-</sup>
<xref rid="B04" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>,</sup>
<xref rid="B06" ref-type="bibr">
<sup>6</sup>
</xref>
<sup>)</sup>
</p>
        <p>As PFR mostram geralmente um padr&#xE3;o restritivo, caracterizado por uma diminui&#xE7;&#xE3;o da
CVF e da CPT. Na fase cr&#xF4;nica &#xE9; poss&#xED;vel encontrar um padr&#xE3;o obstrutivo, estando a
DLCO geralmente diminu&#xED;da.<sup>(</sup>
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>-</sup>
<xref rid="B04" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>,</sup>
<xref rid="B06" ref-type="bibr">
<sup>6</sup>
</xref>
<sup>)</sup>
</p>
        <p>O lavado broncoalveolar (LBA) apresenta um predom&#xED;nio de linf&#xF3;citos (&gt; 60%),
nomeadamente os linf&#xF3;citos T supressores (CD8+), com uma diminui&#xE7;&#xE3;o do &#xED;ndice CD4/CD8
&lt; 1% (raramente encontrado em crian&#xE7;as).<sup>(</sup>
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>-</sup>
<xref rid="B04" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>,</sup>
<xref rid="B06" ref-type="bibr">
<sup>6</sup>
</xref>
<sup>)</sup>
</p>
        <p>As altera&#xE7;&#xF5;es na radiografia pulmonar surgem em fun&#xE7;&#xE3;o do grau de doen&#xE7;a e
relacionam-se pouco com a gravidade dos sintomas, variando de normal a um padr&#xE3;o
nodular/reticulonodular (na forma aguda e subaguda).<sup>(</sup>
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>-</sup>
<xref rid="B06" ref-type="bibr">
<sup>6</sup>
</xref>
<sup>)</sup> A TCAR de t&#xF3;rax pode mostrar um padr&#xE3;o micronodular difuso (fase aguda)
ou enfisema obstrutivo, les&#xF5;es fibr&#xF3;ticas intersticiais e imagens em vidro fosco
(fase cr&#xF4;nica),<sup>(</sup>
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>-</sup>
<xref rid="B07" ref-type="bibr">
<sup>7</sup>
</xref>
<sup>)</sup> sendo o exame de maior utilidade no diagn&#xF3;stico.</p>
        <p>O tratamento consiste na aus&#xEA;ncia de contato com o ant&#xED;geno, podendo ser o &#xFA;nico
tratamento nas formas agudas. A corticoterapia sist&#xEA;mica &#xE9; o tratamento de escolha
nas formas subagudas e cr&#xF4;nicas.<sup>(</sup>
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>-</sup>
<xref rid="B04" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>,</sup>
<xref rid="B06" ref-type="bibr">
<sup>6</sup>
</xref>
<sup>)</sup> O progn&#xF3;stico varia da recupera&#xE7;&#xE3;o completa nas formas agudas e n&#xE3;o
progressivas &#xE0; fibrose pulmonar nas formas cr&#xF4;nicas. O grau de fibrose pulmonar no
momento do diagn&#xF3;stico &#xE9; o principal fator progn&#xF3;stico.<sup>(</sup>
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>,</sup>
<xref rid="B02" ref-type="bibr">
<sup>2</sup>
</xref>
<sup>)</sup>
</p>
      </sec>
      <sec>
        <title>Relato de casos</title>
        <p>Caso 1</p>
        <p>Relatamos o caso de um menino de 12 anos com hist&#xF3;ria de asma e hist&#xF3;ria familiar de
PH. Residente em zona rural, tinha contato com pombos e can&#xE1;rios, que agravavam os
sintomas. Chegou ao servi&#xE7;o de urg&#xEA;ncia com tosse produtiva e febre com 2 dias de
evolu&#xE7;&#xE3;o, associadas a anorexia e perda ponderal. A radiografia tor&#xE1;cica revelou um
infiltrado peri-hilar bilateral, e o paciente teve alta ap&#xF3;s ser medicado com
claritromicina, que foi substitu&#xED;da pela associa&#xE7;&#xE3;o amoxicilina e &#xE1;cido clavul&#xE2;nico
por persist&#xEA;ncia da sintomatologia 5 dias mais tarde. Um m&#xEA;s depois, por manter tosse
intermitente com per&#xED;odos de agravamento e dispneia aos pequenos esfor&#xE7;os, o paciente
foi novamente atendido, apresentando cianose peribucal, palidez cut&#xE2;nea, hipoxemia
(SpO<sub>2</sub> = 85% em ar ambiente), tiragem global e diminui&#xE7;&#xE3;o global dos
sons respirat&#xF3;rios, com estertores nas bases. Os exames complementares revelaram VHS
de 36 mm/h; PCR de 22,8 mg/L; n&#xED;veis de IgA e IgG elevados; teste
Phadiatop<sup>(r)</sup> (Phadia, Uppsala, Su&#xE9;cia) inalat&#xF3;rio e alimentar negativo;
PPD de 0 mm; teste do suor de 34 mEq/L; radiografia tor&#xE1;cica com infiltrado
peri-hilar e basal de padr&#xE3;o reticulonodular bilateralmente (<xref ref-type="fig" rid="f04">Figura 1</xref>); ecocardiograma sem altera&#xE7;&#xF5;es; TCAR de t&#xF3;rax com
consolida&#xE7;&#xE3;o do espa&#xE7;o a&#xE9;reo e broncograma a&#xE9;reo em ambos os lobos inferiores,
associados a padr&#xE3;o intersticial bilateral de distribui&#xE7;&#xE3;o difusa, padr&#xE3;o
centrilobular com alguns micron&#xF3;dulos e &#xE1;reas em vidro fosco; sorologia para
<italic>Chlamydophila psittaci</italic> negativa; PFR indicando altera&#xE7;&#xE3;o
ventilat&#xF3;ria obstrutiva leve; defeito moderado na DLCO; e LBA com alveolite
linfoc&#xED;tica intensa, com franco predom&#xED;nio de CD8+ (rela&#xE7;&#xE3;o CD4/CD8 &lt; 0,3%).
Realizou corticoterapia oral durante um ano com resolu&#xE7;&#xE3;o completa da sintomatologia
e das les&#xF5;es &#xE0; TCAR de t&#xF3;rax, bem como melhoria nos resultados de PFR ao fim de tr&#xEA;s
anos de seguimento.</p>
        <p>
<fig id="f04" orientation="portrait" position="float"><label>Figura 1</label><caption><title>Radiografia de t&#xF3;rax revelando infiltrado peri-hilar e basal de padr&#xE3;o
reticulonodular bilateralmente.</title></caption><graphic xlink:href="1806-3713-jbpneu-40-02-00183-gf01-pt"/></fig>
</p>
      </sec>
      <sec>
        <title>Caso 2 </title>
        <p>Uma menina de 14 anos, residente em zona rural, com p&#xE1;ssaros no domic&#xED;lio e hist&#xF3;ria
familiar de PH. A paciente estava saud&#xE1;vel at&#xE9; novembro de 2002, quando recorreu ao
servi&#xE7;o de urg&#xEA;ncia por febre e tosse; ao exame objetivo, apresentava estertores e
dificuldade respirat&#xF3;ria. Realizou radiografia tor&#xE1;cica, que revelou infiltrado
intersticial. A paciente recebeu alta, sendo medicada com claritromicina e
prednisolona. Retornou ao servi&#xE7;o ambulatorial uma semana depois, referindo dispneia
aos pequenos esfor&#xE7;os. Os exames complementares revelaram VHS de 24 mm/h; aumento do
n&#xED;vel de IgG, mas sem altera&#xE7;&#xF5;es das outras imunoglobulinas; sorologias para
Mycoplasma pneumoniae e Chlamydia pneumoniae negativas; IgG e IgM negativas;
radiografia tor&#xE1;cica com aumento da trama broncovascular bilateralmente e infiltrado
intersticial difuso de predom&#xED;nio peri-hilar bilateral; TCAR de t&#xF3;rax com t&#xEA;nue
adensamento do par&#xEA;nquima pulmonar de ambos os pulm&#xF5;es com distribui&#xE7;&#xE3;o ligeiramente
heterog&#xEA;nea, revelando pequenos n&#xF3;dulos de limites mal definidos e altera&#xE7;&#xF5;es em
vidro fosco (<xref ref-type="fig" rid="f05">Figura 2</xref>); ecocardiograma e
eletrocardiograma sem altera&#xE7;&#xF5;es; LBA com alveolite linfoc&#xED;tica intensa e
neutrof&#xED;lica discreta, com franco predom&#xED;nio de CD8+ (rela&#xE7;&#xE3;o CD4/CD8 &lt; 0,1%). A
paciente foi mantida sob corticoterapia inalat&#xF3;ria durante 2 anos, com melhoria
cl&#xED;nica progressiva.</p>
        <p>
<fig id="f05" orientation="portrait" position="float"><label>Figura 2</label><caption><title>TCAR de t&#xF3;rax revelando t&#xEA;nue adensamento do par&#xEA;nquima pulmonar de
ambos os pulm&#xF5;es, com distribui&#xE7;&#xE3;o heterog&#xEA;nea; pequenos n&#xF3;dulos de limites
mal definidos e altera&#xE7;&#xF5;es em vidro fosco.</title></caption><graphic xlink:href="1806-3713-jbpneu-40-02-00183-gf02-pt"/></fig>
</p>
      </sec>
      <sec>
        <title>Caso 3</title>
        <p>Um menino de 7 anos, cujos pai e av&#xF3; paterna estavam sendo investigados pelo setor de
pneumologia por suspeita de PH. Tinha hist&#xF3;ria pessoal de <italic>situs inversus
totalis</italic> e infec&#xE7;&#xF5;es respirat&#xF3;rias de repeti&#xE7;&#xE3;o. Deu entrada no servi&#xE7;o de
urg&#xEA;ncia por tosse produtiva com cinco meses de evolu&#xE7;&#xE3;o, associada a dispneia aos
esfor&#xE7;os e de agravamento progressivo, sem melhoria com broncodilatador e
corticoterapia inalat&#xF3;ria. Foi relatada a exist&#xEA;ncia de um periquito no domic&#xED;lio
desde o in&#xED;cio da sintomatologia, bem como um galinheiro e uma oficina de tanoaria.
Ao exame inicial, apresentava SpO<sub>2</sub> de 84% em ar ambiente, tiragem
subcostal e estertores bilaterais. Os exames complementares revelaram VHS de 30 mm/h;
PCR de 1,41 mg/dL; aumento dos n&#xED;veis de IgG, IgA e IgM; sorologias para Mycoplasma
pneumoniae, Legionella pneumophila e Chlamydia pneumoniae (IgG e IgM) negativas;
radiografia tor&#xE1;cica com infiltrado peri-hilar e intersticial difuso bilateral; teste
do suor de 32 mEq/L; PPD de 0 mm; precipitinas s&#xE9;ricas para fezes e penas de aves
negativas; ecocardiograma com situs inversus completo; TCAR de t&#xF3;rax com exuberantes
altera&#xE7;&#xF5;es em vidro fosco em ambos os campos pulmonares, compat&#xED;vel com alveolite
al&#xE9;rgica extr&#xED;nseca (<xref ref-type="fig" rid="f06">Figura 3</xref>); PFR indicando
altera&#xE7;&#xE3;o obstrutiva grave sem resposta ao broncodilatador; LBA com alveolite
linfoc&#xED;tica intensa e neutrofilia, com franco predom&#xED;nio de CD8+ (rela&#xE7;&#xE3;o CD4/CD8
&lt; 0,1%). O paciente recebeu corticoterapia inalat&#xF3;ria durante 2 anos, com melhoria
cl&#xED;nica e radiol&#xF3;gica progressiva.</p>
        <p>
<fig id="f06" orientation="portrait" position="float"><label>Figura 3</label><caption><title>TCAR de t&#xF3;rax revelando exuberantes altera&#xE7;&#xF5;es em vidro fosco em ambos
os campos pulmonares, compat&#xED;vel com alveolite al&#xE9;rgica extr&#xED;nseca.</title></caption><graphic xlink:href="1806-3713-jbpneu-40-02-00183-gf03-pt"/></fig>
</p>
      </sec>
      <sec>
        <title>Discuss&#xE3;o</title>
        <p>Os pacientes descritos apresentavam hist&#xF3;ria familiar de PH associada a um quadro
cl&#xED;nico correspondente &#xE0; forma de apresenta&#xE7;&#xE3;o subaguda de PH, com padr&#xE3;o obstrutivo
e sintomas como tosse, dispneia aos esfor&#xE7;os, perda ponderal e, por vezes, febre,
sintomas esses desencadeados ao fim de algumas semanas a meses de exposi&#xE7;&#xE3;o a um
ant&#xED;geno.</p>
        <p>Para o diagn&#xF3;stico foi essencial um elevado &#xED;ndice de suspei&#xE7;&#xE3;o, bem como crit&#xE9;rios
anal&#xED;ticos e laboratoriais. Entre os crit&#xE9;rios maiores, definidos por Schuyler et
al.,<sup>(</sup>
<xref rid="B07" ref-type="bibr">
<sup>7</sup>
</xref>
<sup>)</sup> encontram-se os sintomas compat&#xED;veis, a evid&#xEA;ncia de exposi&#xE7;&#xE3;o a
ant&#xED;geno mediante a hist&#xF3;ria cl&#xED;nica, os achados radiol&#xF3;gicos na radiografia e na TC
compat&#xED;veis com PH e a presen&#xE7;a de linfocitose no LBA. Dentre os crit&#xE9;rios menores,
destacam-se a exist&#xEA;ncia de estertores nas bases e hipoxemia arterial. Apenas em um
dos pacientes se documentou uma diminui&#xE7;&#xE3;o da DLCO. Em nenhum dos casos foi poss&#xED;vel
identificar anticorpos precipitantes para o ant&#xED;geno. Apesar de esses serem
marcadores objetivos de exposi&#xE7;&#xE3;o, a sua negatividade n&#xE3;o exclui em absoluto o
diagn&#xF3;stico.<sup>(</sup>
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>-</sup>
<xref rid="B04" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>,</sup>
<xref rid="B06" ref-type="bibr">
<sup>6</sup>
</xref>
<sup>)</sup>
</p>
        <p>Nesses tr&#xEA;s casos foi poss&#xED;vel verificar a presen&#xE7;a de um padr&#xE3;o
reticulonodular/intersticial difuso na radiografia tor&#xE1;cica, bem como a exist&#xEA;ncia de
um padr&#xE3;o em vidro fosco, &#xE1;reas em vidro fosco e micron&#xF3;dulos, caracter&#xED;sticos da
forma subaguda.</p>
        <p>A presen&#xE7;a de linfocitose no LBA dos pacientes, bem como a exist&#xEA;ncia de uma rela&#xE7;&#xE3;o
CD4/CD8 &lt; 0,1% em dois deles, permitiu corroborar o diagn&#xF3;stico de PH.</p>
        <p>Dada a inexist&#xEA;ncia de forma grave da doen&#xE7;a, o tratamento institu&#xED;do em todos os
pacientes foi a aus&#xEA;ncia de contato com o al&#xE9;rgeno e a utiliza&#xE7;&#xE3;o de corticoterapia
oral/inalat&#xF3;ria, que resultou em melhoria cl&#xED;nica progressiva, assim como a dos
par&#xE2;metros ventilat&#xF3;rios e radiol&#xF3;gicos.</p>
        <p>A realiza&#xE7;&#xE3;o de bi&#xF3;psia pulmonar deve ser ponderada mediante sua rela&#xE7;&#xE3;o
custo-benef&#xED;cio, devendo ser considerada em raros casos nos quais haja d&#xFA;vida no
diagn&#xF3;stico ou naqueles cuja evolu&#xE7;&#xE3;o cl&#xED;nica ou resposta ao tratamento seja
d&#xFA;bia.<sup>(</sup>
<xref rid="B03" ref-type="bibr">
<sup>3</sup>
</xref>
<sup>)</sup>
</p>
        <p>A PH &#xE9; uma patologia pouco frequente em crian&#xE7;as e apresenta sintomas inespec&#xED;ficos.
Para o seu diagn&#xF3;stico, &#xE9; importante a cl&#xED;nica e a investiga&#xE7;&#xE3;o de exposi&#xE7;&#xE3;o a
al&#xE9;rgenos. Em todos os casos descritos havia hist&#xF3;ria familiar de PH, apesar de n&#xE3;o
ter sido investigada a presen&#xE7;a de HLA. Esses fatos levam-nos a acreditar que apesar
de o al&#xE9;rgeno ser o principal fator desencadeante dessa patologia, a hereditariedade
tamb&#xE9;m se apresenta como um importante cofator. &#xC9; fundamental o diagn&#xF3;stico precoce
de PH, o que permite se evitar complica&#xE7;&#xF5;es irrevers&#xED;veis e graves, como a fibrose
pulmonar.</p>
      </sec>
    </body>
    <back>
      <fn-group>
        <fn id="fn02" fn-type="other">
          <label>*</label>
          <p>Trabalho realizado no Centro Hospitalar de Vila Nova de Gaia/Espinho, Porto,
Portugal.</p>
        </fn>
        <fn fn-type="financial-disclosure">
          <p>Apoio financeiro: Nenhum.</p>
        </fn>
      </fn-group>
    </back>
  </sub-article>
</article>
</pmc-articleset>
